Evidence map›Paper›PMID 40007608›Full record

ReviewFrontiers in cellular and infection microbiology2025

Role of E-cadherin in epithelial barrier dysfunction: implications for bacterial infection, inflammation, and disease pathogenesis.

Peter Lialios, Stella Alimperti

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. The journal of advanced prosthodontics · 2026
    Article
  7. Review
  8. The Role of Selected Bacteria in Breast Cancer Initiation and Development.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Molecules (Basel, Switzerland) · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peter LialiosDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC, United States.
Stella AlimpertiDepartment of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC, United States.

Funding

Regulation of epithelial barrierR01DE031046 · NIDCR · GEORGETOWN UNIVERSITY · PI ALIMPERTI, STELLA, GRAVES, DANA T · 2021 to 2025
$2.3M
3D bioengineered microfluidic platform for research on Ewing sarcoma bone metastasisR21CA294025 · NCI · GEORGETOWN UNIVERSITY · PI ALIMPERTI, STELLA, KITLINSKA, JOANNA B. · 2024 to 2024
$401k
NCI NIH HHS R21 CA294025NIDCR NIH HHS R01 DE031046
6 · The paper itself

Abstract

Epithelial barriers serve as critical defense lines against microbial infiltration and maintain tissue homeostasis. E-cadherin, an essential component of adherens junctions, has emerged as a pivotal molecule that secures epithelial homeostasis. Lately, its pleiotropic role beyond barrier function, including its involvement in immune responses, has become more evident. Herein, we delve into the intricate relationship between (dys)regulation of epithelial homeostasis and the versatile functionality of E-cadherin, describing complex mechanisms that underlie barrier integrity and disruption in disease pathogenesis such as bacterial infection and inflammation, among others. Clinical implications of E-cadherin perturbations in host pathophysiology are emphasized; downregulation, proteolytic phenomena, abnormal localization/signaling and aberrant immune reactions are linked with a broad spectrum of pathology beyond infectious diseases. Finally, potential therapeutic interventions that may harness E-cadherin to mitigate barrier-associated tissue damage are explored. Overall, this review highlights the crucial role of E-cadherin in systemic health, offering insights that could pave the way for strategies to reinforce/restore barrier integrity and treat related diseases.

Indexed as

Bacterial InfectionsCadherinsEpithelial CellsInflammationAdherens JunctionsAnimalsEpitheliumHomeostasisHumansSignal TransductionCadherinsbacteriadisease pathogenesisE-cadherinepithelial barrierhomeostasisinfectioninflammation

Identifiers

PMID40007608
PMCPMC11850337

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.